STOCK TITAN

Agarwal Trust sells multiple 20,000 shares (DDOG) under 10b5‑1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Issuer: DDOG Form 144 notice reports proposed and recent sales of Class A Common stock by the Agarwal 2018 Family Trust. The filing lists multiple 10b5-1 programmed sales of 20,000 shares each on 03/09/2026, 03/16/2026, 03/23/2026, 04/01/2026, 04/08/2026, 04/15/2026, and 04/20/2026, with gross proceeds shown for each sale. The cover line shows a proposed sale of 20,000 shares with an aggregate amount listed as $2,589,600.00.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists scheduled 10b5-1 dispositions by a family trust; multiple 20,000-share trades are reported.

The filing documents proposed and completed sales of Class A Common stock under a Rule 10b5-1 plan, showing discrete sale dates and gross proceeds per trade. The trust is the selling holder named throughout the excerpt.

Cash‑flow treatment to issuer is not stated in the excerpt; regulatory mechanics for Form 144 filing and broker execution would follow standard resale procedures.

Proposed shares on cover 20,000 shares cover/proposed sale line
Aggregate amount shown on cover $2,589,600.00 cover line associated with 20,000 shares
Sale on 03/09/2026 20,000 shares 10b5-1 sale listing dated 03/09/2026 with proceeds $2,496,116.00
Sale on 03/16/2026 20,000 shares 10b5-1 sale listing dated 03/16/2026 with proceeds $2,534,672.00
Sale on 04/20/2026 20,000 shares 10b5-1 sale listing dated 04/20/2026 with proceeds $2,519,524.00
10b5-1 regulatory
"10b5-1 Sales for AGARWAL 2018 FAMILY TRUST 620 8th Avenue"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Previously Exercised Stock Options financial
"Previously Exercised Stock Options | Issuer | 20000 | 04/07/2021"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does DDOG Form 144 disclose about the Agarwal 2018 Family Trust?

It discloses planned and completed sales of Class A Common stock by the Agarwal 2018 Family Trust. The excerpt lists multiple 20,000-share sales executed under a 10b5-1 plan on specific dates in March–April 2026.

How many shares were sold under the 10b5-1 plan in the excerpt?

The excerpt shows multiple discrete sales of 20,000 shares each. Sales dated 03/09/2026 through 04/20/2026 are listed, each with separate gross proceeds figures.

What proceeds are shown for the sales in the filing?

Each listed 20,000-share transaction includes a gross proceeds figure, for example $2,496,116.00 on 03/09/2026 and $2,519,524.00 on 04/20/2026. Other sale dates show similar per-trade amounts in the excerpt.

Was the issuer selling shares or were these resales by a holder?

The excerpt identifies the transactions as 10b5-1 Sales for the Agarwal 2018 Family Trust, indicating these are resales by a selling holder rather than primary issuer sales in this excerpt.

Does the Form 144 excerpt state whether proceeds go to the issuer?

The excerpt does not state the issuer’s receipt of proceeds; it lists sales by the Agarwal 2018 Family Trust. The filing language and table indicate these are resale transactions by the named trust.